Xilong Scientific Balance Sheet Health
Financial Health criteria checks 3/6
Xilong Scientific has a total shareholder equity of CN¥2.3B and total debt of CN¥1.2B, which brings its debt-to-equity ratio to 51%. Its total assets and total liabilities are CN¥4.9B and CN¥2.6B respectively. Xilong Scientific's EBIT is CN¥82.3M making its interest coverage ratio 2.3. It has cash and short-term investments of CN¥471.6M.
Key information
51.0%
Debt to equity ratio
CN¥1.20b
Debt
| Interest coverage ratio | 2.3x |
| Cash | CN¥471.60m |
| Equity | CN¥2.35b |
| Total liabilities | CN¥2.56b |
| Total assets | CN¥4.90b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002584's short term assets (CN¥3.5B) exceed its short term liabilities (CN¥2.1B).
Long Term Liabilities: 002584's short term assets (CN¥3.5B) exceed its long term liabilities (CN¥463.3M).
Debt to Equity History and Analysis
Debt Level: 002584's net debt to equity ratio (30.9%) is considered satisfactory.
Reducing Debt: 002584's debt to equity ratio has increased from 38.7% to 51% over the past 5 years.
Debt Coverage: 002584's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 002584's interest payments on its debt are not well covered by EBIT (2.3x coverage).